MEK4 IN-3
MEK4 IN-3 (Compound 39) is a selective MEK4 inhibitor with IC50s of 78 and 2920 nM for MEK4 and RSK4, respectively. MEK4 IN-3 reduces toxicity in cells. MEK4 IN-3 can be used for liver failure, particularly nonalcoholic fatty liver disease (NAFLD) research.
For research use only. We do not sell to patients.
- Formula: C18H16FN5O2
- Molecular Weight:353.35
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All MEK Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
MAP2K4/MEK4 78 nM (IC50) |
Chemical Information
-
Molecular Weight 353.35
-
Formula C18H16FN5O2
-
SMILES
N#CC1=CC(NC2=CC(N(C3CC3)C4)=C(C=N2)N(C)C4=O)=CC(F)=C1O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)